Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | Director | December 31, 2025 | January 05, 2026 |
| METLIFE INCMET · Entity 488 | EVP - Gl. Chief Marketing Off. | June 14, 2021 | June 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,610.3691 |
Reported balance
After 2025-02-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-02-14 · Grant · Acquired 111.336 · Balance 13,610.3691 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,733.5856 |
Reported balance
After 2025-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-09 · Grant · Acquired 123.2165 · Balance 13,733.5856 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,877.6604 |
Reported balance
After 2025-08-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-08-29 · Grant · Acquired 144.0748 · Balance 13,877.6604 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,039.5751 |
Reported balance
After 2025-11-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-06 · Grant · Acquired 161.9147 · Balance 14,039.5751 F1: 1-for-1 F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,677.4328 |
Reported balance
After 2025-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-12-31 · Grant · Acquired 1,637.8577 · Balance 15,677.4328 F1: 1-for-1 F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
METLIFE INC
Report date June 14, 2021 · Filed June 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,956 |
Reported balance
After 2021-06-14 transaction · row 1
1 source rowRow 1 · 2021-06-14 · Grant · Acquired 178 · Balance 56,956 F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. |
Filing footnotes · ownership attribution and instrument terms
F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2025 Filed Jan 5, 2026 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,637.8577 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000175 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,677.4328 Underlying: Common Stock · 1,637.8577 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 06, 2025 Filed Jan 5, 2026 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 161.9147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000175 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,039.5751 Underlying: Common Stock · 161.9147 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 29, 2025 Filed Jan 5, 2026 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 144.0748 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000175 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,877.6604 Underlying: Common Stock · 144.0748 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 09, 2025 Filed Jan 5, 2026 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 123.2165 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000175 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,733.5856 Underlying: Common Stock · 123.2165 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2025 Filed Jan 5, 2026 21:45 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 111.336 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-000175 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,610.3691 Underlying: Common Stock · 111.336 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,000.7162 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000210 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,499.0331 Underlying: Common Stock · 1,000.7162 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 07, 2024 Filed Jan 3, 2025 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 92.981 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000210 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,498.317 Underlying: Common Stock · 92.981 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 30, 2024 Filed Jan 3, 2025 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 94.8694 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000210 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,405.336 Underlying: Common Stock · 94.8694 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 10, 2024 Filed Jan 3, 2025 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 102.1969 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000210 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,310.4666 Underlying: Common Stock · 102.1969 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 09, 2024 Filed Jan 3, 2025 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 94.8829 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-000210 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,208.2697 Underlying: Common Stock · 94.8829 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,117.3538 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000250 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,113.3868 Underlying: Common Stock · 1,117.3538 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 09, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 98.8259 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000250 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,996.033 Underlying: Common Stock · 98.8259 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 25, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 83.97 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000250 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,897.2071 Underlying: Common Stock · 83.97 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 12, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 74.92 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000250 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,813.2371 Underlying: Common Stock · 74.92 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 10, 2023 Filed Jan 3, 2024 21:44 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 83.5336 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-000250 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,738.3171 Underlying: Common Stock · 83.5336 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 1,073.3191 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000264 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,654.7835 Underlying: Common Stock · 1,073.3191 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 10, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 77.8874 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000264 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,581.4645 Underlying: Common Stock · 77.8874 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 12, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 76.0029 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000264 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,503.5771 Underlying: Common Stock · 76.0029 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| May 13, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 68.59 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000264 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,427.5742 Underlying: Common Stock · 68.59 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 11, 2022 Filed Jan 4, 2023 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 74.7687 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-000264 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,358.9842 Underlying: Common Stock · 74.7687 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 918.6024 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000183 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,284.2155 Underlying: Common Stock · 918.6024 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 10, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 58.248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000183 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,365.6132 Underlying: Common Stock · 58.248 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 13, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 56.8159 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000183 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,307.3652 Underlying: Common Stock · 56.8159 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:00 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 178 | $63.31 | $11,269.18 |
DisclosureSEC source: 0001099219-21-000217 · wf-form4_162389159037408.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,956 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:20 UTC | METLIFE INC MET · Entity 488 | SaleCommon Stock | 7,800 | $64.76 | $505,166.22 |
DisclosureSEC source: 0001099219-21-000189 · wf-form4_162154198828709.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,779 F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices of $64.76 to $64.765, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 07, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 49.7399 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000183 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,250.5493 Underlying: Common Stock · 49.7399 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:58 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 177 | $60.54 | $10,715.58 |
DisclosureSEC source: 0001099219-21-000129 · wf-form4_161601470796776.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,579 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:58 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 702 | $58.96 | $41,389.92 |
DisclosureSEC source: 0001099219-21-000098 · wf-form4_161480869899705.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,402 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:58 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 1,415 | $59.44 | $84,107.60 |
DisclosureSEC source: 0001099219-21-000098 · wf-form4_161480869899705.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,104 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Options (right to buy) · Derivative | 9,797 | $0.00 Strike: $57.43 | $0.00 |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,797 Underlying: Common Stock · 9,797 shares Expires 2031-02-22 F5 · derivative.exercise_date: The options become exercisable in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 8,293 | $57.43 | $476,266.99 |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 3 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,519 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 20,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,812 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:35 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 3,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-21-000074 · wf-form4_161429246914206.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,357 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: Includes 7,948 restricted stock units previously reported on Table II. Read SEC document |
| February 12, 2021 Filed Jan 4, 2022 21:18 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 48.6578 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-000183 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200.8094 Underlying: Common Stock · 48.6578 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 777.268 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,152.1516 Underlying: Common Stock · 777.268 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:08 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 231 | $45.84 | $10,589.04 |
DisclosureSEC source: 0001099219-20-000386 · wf-form4_160815648516424.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,144 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| November 20, 2020 Filed Jan 5, 2021 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 40.0966 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,374.8836 Underlying: Common Stock · 40.0966 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:27 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 269 | $38.84 | $10,447.96 |
DisclosureSEC source: 0001099219-20-000317 · wf-form4_160028803639300.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,913 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 36.1271 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,334.787 Underlying: Common Stock · 36.1271 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 20:59 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 276 | $37.45 | $10,336.20 |
DisclosureSEC source: 0001099219-20-000242 · wf-form4_159234117439455.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,643 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| May 08, 2020 Filed Jan 5, 2021 21:20 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantDeferred Stock Units · Derivative | 37.7192 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 2 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,298.6599 Underlying: Common Stock · 37.7192 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:11 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 176 | $31.93 | $5,619.68 |
DisclosureSEC source: 0001099219-20-000154 · wf-form4_158449385613568.xml · nonDerivative · entry 1 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,367 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · derivative · entry 9 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,688 Underlying: Common Stock · 1,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · derivative · entry 8 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319 Underlying: Common Stock · 1,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionRestricted Stock Units · Derivative | 1,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · derivative · entry 7 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · shares: Includes 191 restricted stock units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the restricted stock units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the restricted stock units. F4 · derivative.exercise_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F4 · derivative.expiration_date: The restricted stock units vest in three substantially equal installments on the first business day in March on or following each of the first three anniversaries of the grant date. F3 · derivative.underlying_shares: Includes 191 restricted stock units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the restricted stock units in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the restricted stock units. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 514 | $44.56 | $22,903.84 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 6 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,190 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 5 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 505 | $44.56 | $22,502.80 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 4 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,360 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Exercise / conversionCommon Stock | 1,319 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 3 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:24 UTC | METLIFE INC MET · Entity 488 | Tax withholdingCommon Stock | 681 | $44.56 | $30,345.36 |
DisclosureSEC source: 0001099219-20-000125 · wf-form4_158335703824738.xml · nonDerivative · entry 2 Lee Esther · CIK 0001585015 · EVP - Gl. Chief Marketing Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,546 F2 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the restricted stock unit payout. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.